Polsinelli has announced the strategic recruitment of Stacie Ropka as a senior partner within its Hatch-Waxman Act and biologics practice. Based in Washington, Ropka brings with her a wealth of experience within the biotech and life sciences sectors, offering expert legal counsel on matters related to the Hatch-Waxman Act and related issues. Her role will also encompass advising clients on due diligence, with a particular emphasis on reconstructive biomaterials, biologics, and biologic-based pharmaceuticals. This move is part of Polsinelli’s ongoing efforts to bolster its life sciences expertise and capabilities.
Ropka’s addition to the firm is viewed as a significant enhancement to Polsinelli’s existing legal team. Her expertise in navigating complex regulatory environments and her extensive industry knowledge make her a valuable asset for companies operating in these highly regulated sectors. As the biotech and life sciences industries continue to evolve, Ropka’s guidance is expected to provide critical insights to companies striving to innovate and comply with regulatory demands. More details about her appointment can be found in the announcement by the firm.